From 965 Billion to 2 Trillion, Without a Public Filing

Anthropic confidentially filed a draft registration statement with the U.S. Securities and Exchange Commission on June 1, 2026, days after closing a 65 billion dollar Series H round that valued the company at 965 billion dollars. Bloomberg reported on July 15 that investor meetings had begun, with market expectation pointing to a fall debut. By August 13, Fortune, Forbes, and several other outlets reported that Anthropic and its bankers were now discussing a target valuation of 2 trillion dollars for an October listing - more than double the figure this outlet covered just two days earlier, on August 11.

None of this is confirmed by Anthropic itself. The reporting is sourced to people familiar with the discussions, and multiple outlets note the valuation has not been formally fixed, with some prospective investors reportedly building their own financial models rather than accepting a company-set number. That distinction matters: a reported target moving by more than a trillion dollars in ten weeks is not the same as a company revising its own valuation twice - it is closer to a live negotiation being reported in real time, before any binding number exists.

The Revenue Case Banks Are Selling

The number behind the number is growth. Anthropic's run-rate revenue went from roughly 1 billion dollars in December 2024 to 47 billion dollars in May 2026, and the new reports cite forecasts of 100 billion to 120 billion dollars in annual revenue by the end of 2026 - more than a hundredfold growth in under two years, if the higher end of that forecast holds. Institutional investors reportedly put nearly 100 billion dollars into Anthropic during 2026 alone, a wave of capital that pushed its valuation above OpenAI's for the first time in May.

Morgan Stanley, Goldman Sachs, and JPMorgan are named as the banks leading the offering, according to Fortune's reporting. The same coverage flags real uncertainty sitting underneath the growth story: a dispute between Anthropic and the Trump administration, and separately with the US Defense Department, both of which are described as unresolved as of this writing - a regulatory and legal overhang that any prospectus will eventually have to address in more detail than a press report can.

What 'the Largest IPO Ever' Actually Means

Multiple outlets describe a 2 trillion dollar Anthropic listing as potentially the largest public share offering ever, eclipsing SpaceX. That framing is about scale, not multiple: run the same arithmetic across both reported valuations and the price investors are effectively paying per dollar of revenue barely moved. At 965 billion dollars against a 47 billion dollar run-rate, the implied multiple was roughly 20.5 times. At 2 trillion dollars against the midpoint of a 100-120 billion dollar forecast, it works out to roughly 18 times - marginally cheaper on this specific measure, not more expensive.

That is the detail missing from most coverage of the bigger number: Anthropic is not being priced more richly per dollar of revenue than it was in June. The valuation moved because the revenue forecast moved, by a comparable multiple. Whether that forecast holds is the entire question a public listing will eventually have to answer in audited numbers, not projections attributed to unnamed sources.

Why the Number You Read Today Won't Be the One That Prices

For anyone using a reported Anthropic valuation as a reference point - to benchmark other AI-sector deals, to value a fund stake with Anthropic exposure, or simply to gauge how large the AI capital cycle has become - both 965 billion and 2 trillion dollars are snapshots of an unfinished negotiation, not confirmed facts. The June S-1 was confidential and remains unpublished in detail; the October target is, by multiple outlets' own account, still being modeled rather than fixed. A number that has already moved by more than a trillion dollars in ten weeks is not a stable anchor for anyone's spreadsheet.

The number that will eventually matter is the one that appears in a public S-1 with an actual price range, set closer to the listing date and tested by underwriters who have to defend it to real buyers, not the one reported today by people familiar with an internal discussion. Until that filing exists, the sensible move for anyone with Anthropic-adjacent exposure is to treat every headline valuation as provisional and re-check it against the next confirmed filing, rather than build a financial model on a figure that is still, by its own sourcing, in motion.